| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2009 | US20090176814 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 07/09/2009 | US20090176813 Aqueous suspensions of tmc278 |
| 07/09/2009 | US20090176812 3 -(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H) -one; for cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
| 07/09/2009 | US20090176811 Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds |
| 07/09/2009 | US20090176810 Composition for skin external application containing gallocatechin gallate for moisturizing effect on the skin |
| 07/09/2009 | US20090176809 Raf inhibitor compounds and methods |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176805 Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents |
| 07/09/2009 | US20090176804 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 07/09/2009 | US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
| 07/09/2009 | US20090176802 Antidotes to exogenous neurotoxic agents |
| 07/09/2009 | US20090176801 Novel lapachone compounds and methods of use thereof |
| 07/09/2009 | US20090176800 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176798 New compounds III |
| 07/09/2009 | US20090176797 Pharmaceutical composition for treating esophageal cancer |
| 07/09/2009 | US20090176796 Trpv1 antagonists including amide substituent and uses thereof |
| 07/09/2009 | US20090176795 Enhanced delivery of antifungal agents |
| 07/09/2009 | US20090176794 1h-indol-1-yl-urea compounds |
| 07/09/2009 | US20090176793 3-(l,3-BENZODIOXOL-5-YL)-6-(4-CYCLOPROPYLPIPERAZIN-l-YL)-PYRIDAZINE, ITS SALTS AND SOLVATES AND ITS USE AS HISTAMINE H3 RECEPTOR ANTAGONIST |
| 07/09/2009 | US20090176792 Substituted dibenzhydrylpiperazines |
| 07/09/2009 | US20090176791 Diaryl Ureas for Treating Pulmonary Hypertension |
| 07/09/2009 | US20090176790 Pterin analogs |
| 07/09/2009 | US20090176789 Diazaspirodecane orexin receptor antagonists |
| 07/09/2009 | US20090176788 Imidazo[1,2-B]Pyridazines, Processes, Uses, Intermediates and Compositions |
| 07/09/2009 | US20090176787 Crystalline Forms of lamotrigine |
| 07/09/2009 | US20090176785 Method of treating arthritis |
| 07/09/2009 | US20090176784 Anti-infective agents and uses thereof |
| 07/09/2009 | US20090176783 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176781 Acetylenic Heteroaryl Compounds |
| 07/09/2009 | US20090176780 Nitrogenous heterocyclic compounds |
| 07/09/2009 | US20090176779 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapeutic application thereof |
| 07/09/2009 | US20090176778 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 07/09/2009 | US20090176777 Imidazo (1,2-a)Pyridin-3-YL-Acetic Acid Hydrazides, Proesses for Their Preparation and Pharmaceutical Uses Thereof |
| 07/09/2009 | US20090176776 Small molecule inhibitors of hiv-1 capsid assembly |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176774 Compounds and methods of use |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176772 Method of reversing left ventricular remodeling |
| 07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
| 07/09/2009 | US20090176770 e.g. 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4.5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/09/2009 | US20090176769 Cgrp receptor antagonists |
| 07/09/2009 | US20090176768 Diaza heterocyclic amide compounds and their uses |
| 07/09/2009 | US20090176767 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma |
| 07/09/2009 | US20090176766 Imidazolidinone and imidazolidinethione derivatives |
| 07/09/2009 | US20090176765 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) |
| 07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 07/09/2009 | US20090176762 JNK Inhibitors for Treatment of Skin Diseases |
| 07/09/2009 | US20090176761 JNK Inhivitors for the Treatment of Endometriosis |
| 07/09/2009 | US20090176760 Tricyclic compounds |
| 07/09/2009 | US20090176759 Leukemic stem cell ablation |
| 07/09/2009 | US20090176758 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 07/09/2009 | US20090176757 Bicyclic Spirohydantoin CGRP Receptor Antagonists |
| 07/09/2009 | US20090176756 Substituted thiazoles and their use for producing drugs |
| 07/09/2009 | US20090176755 Pharmaceutical compositions comprising an antibiotic |
| 07/09/2009 | US20090176754 Crystalline Form of the Compound A-348441 |
| 07/09/2009 | US20090176753 Betulinol derivatives as anti-cancer agents |
| 07/09/2009 | US20090176752 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 07/09/2009 | US20090176751 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/09/2009 | US20090176750 Specified ratio of penetration enhancers to solvents and emulsifiers; fluocinolone |
| 07/09/2009 | US20090176749 Oil-in-water emulsion lotion containing 22-oxa-1alpha, 25-dihydroxyvitamin d3 and method of treatment of skin disorder using the same |
| 07/09/2009 | US20090176748 Methods and compositions for controlled release oral dosage of a vitamin d compound |
| 07/09/2009 | US20090176747 Tetracycline compounds and methods of treatment |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176745 Triarylmethane analogs and their use in treating cancers |
| 07/09/2009 | US20090176744 Deuterated fingolimod |
| 07/09/2009 | US20090176743 Methods for treating or preventing reactivation of a latent herpesvirus infection |
| 07/09/2009 | US20090176742 Methods relating to the treatment of fibrotic disorders |
| 07/09/2009 | US20090176741 Modulation of the immune system by inositol phospholipids |
| 07/09/2009 | US20090176740 Treatment of neurological conditions by the co-administration of aniracetam and l-alpha glycerylphosphorylcholine |
| 07/09/2009 | US20090176739 Optical isomers of an iloperidone metabolite |
| 07/09/2009 | US20090176738 Dermal medicament delivery system |
| 07/09/2009 | US20090176737 Composition for Soft Contact Lens and Adsorption Suppressing Method |
| 07/09/2009 | US20090176736 Pharmaceutical composition for conformational diseases |
| 07/09/2009 | US20090176735 Preventing or reducing oxidative stress or oxidative cell injury |
| 07/09/2009 | US20090176734 Method For Simulating The Functional Attributes Of Human Milk Oligosaccharides In Formula-Fed Infants |
| 07/09/2009 | US20090176733 Novel Medicaments for Anti-Herpes Virus Treatments |
| 07/09/2009 | US20090176732 Protected nucleotide analogs |
| 07/09/2009 | US20090176731 Combination therapy of cancer with azd2171 and gemcitabine |
| 07/09/2009 | US20090176730 N4-acylcytosine nucleosides for treatment of viral infections |
| 07/09/2009 | US20090176729 Method of treating neurodegenerative disease |
| 07/09/2009 | US20090176728 Treatment of CNS Conditions |
| 07/09/2009 | US20090176727 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 07/09/2009 | US20090176726 Methods for treating mitf-related disorders |
| 07/09/2009 | US20090176725 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 07/09/2009 | US20090176724 Methods and Compositions for the Diagnosis, Prognosis and Treatment of Cancer |
| 07/09/2009 | US20090176723 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 07/09/2009 | US20090176721 Nucleoside analogs with carboxamidine modified monocyclic base |
| 07/09/2009 | US20090176720 Compositions containing piperacillin and tazobactam useful for injection |
| 07/09/2009 | US20090176719 Compositions and methods for treating perioral dermatitis |
| 07/09/2009 | US20090176718 Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome |
| 07/09/2009 | US20090176717 Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| 07/09/2009 | US20090176716 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 07/09/2009 | US20090176715 Pharmaceutical Compositions and Methods Utilizing a D-Amino Acid |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176706 Materials and methods for treatment of inflammatory and cell proliferation disorders |